ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism

Pas encore traduit Pas encore traduit
Catégorie Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The ULTIMA study is intended to prove that in patients with pulmonary embolism and a right ventricular end diastolic diameter to left ventricular end diastolic diameter ratio ≥1 (RV/LV ratio) will benefit from treatment with ultrasound accelerated thrombolysis (rt-PA) as compared to unfractionated heparin anticoagulation. Specifically, at 24 hours the RV/LV ratio will be significantly reduced in the treatment arm compared to the control arm.
Epistemonikos ID: 57dc9e5aab0452f2f4866d8da70389f81e04702d
First added on: Jun 25, 2016